While immunosuppression is effective in preventing rejection following LT, it may be sub-optimal for some recipients or too aggressive in others, leading to complications of under- or over-immunosuppression. Many programs have a "one size fits all" approach, leading to standard protocols for everyone and only changed when complications occur (rejection or infection, etc). The field needs to move toward more personalized approaches incorporating clinical characteristics, disease states, diagnoses at the time of transplantation, etc in order to optimize immunosuppression therapy. This four-part webinar series will discuss the use of different approaches and the data that support their implementation. Click "Browse Sessions" or "Entire Conference" to view the four sections.
Preview Available
Identification: 001
After participating in this activity, the learner will be able to:
Preview Available
Identification: 002
After participating in this activity, the learner will be able to:
Preview Available
Identification: 004
After participating in this activity, the learner will be able to:
Preview Available
Identification: 003
After participating in this activity, the learner will be able to: